Governance
Author Directory
Released: · Last reviewed:
Pages on this site are researched and drafted by Dr. Parmis (Dr. Parmis Mojarab), Medical Researcher, Western University of Health Sciences, and every page is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) before publication. Author and reviewer roles are kept distinct: authorship covers research and drafting, review covers clinical accuracy.
Key takeaways
- Pages are researched and drafted by Dr. Parmis, Medical Researcher, and published under Tirzepatide Editorial.
- Every page is medically reviewed by both named reviewers, Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC).
- Authorship and clinical review are distinct roles and are recorded separately.
- Reviewer identities, credentials, and NPI verification are published in the reviewer directory.
- No content is attributed to a fabricated author or a stock persona.
| Researched by | Dr. Parmis — Medical Researcher, Western University of Health Sciences |
|---|---|
| Clinical review | Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) — every page |
| Role separation | Authorship and clinical review are recorded separately |
| Fabricated authors | Not used |
| Review dates | Displayed separately from publication dates |
Why separate authorship from clinical review?
Because they answer different questions. Authorship records who researched and wrote a page. Clinical review records that a qualified clinician checked the medical statements against labelling and the literature. Merging them lets a site imply clinical oversight it may not have, which is why the roles and their dates are stored and displayed separately here.
How much of this site's data is actually verified?
| Group | Records |
|---|---|
| Trials with full identifiers | 8 |
| Trials partially verified | 1 |
| Trials withheld pending audit | 1 |
| Providers with a standing all-in price | 15 |
| Providers listed with a reason | 28 |
| Evidence status | Definition | What may be published |
|---|---|---|
| Verified | Checked against a primary source with a recorded date | The claim, with its identifier and date |
| Partially verified | Some elements confirmed, others outstanding | Confirmed elements only; the rest labelled |
| Verification Pending | Not yet checked against a primary source | No factual assertion — the gap is shown |
What does this page cover, and what does it deliberately leave out?
This page addresses Verified authors, experience and articles and conflicts, organised around the primary question of tirzepatide authors. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.
| Element | Treatment here | Evidence basis |
|---|---|---|
| Verified authors | Covered on this page | Regulatory or policy source |
| Experience | Covered on this page | Regulatory or policy source |
| Articles and conflicts | Covered on this page | Regulatory or policy source |
| Individualized clinical instruction | Deliberately not covered | Belongs with the corrections process |
What are the limits of what this page can tell you?
Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
This page would be revised, with the change recorded in its history, if any of the following occurred:
- New primary evidence bearing directly on tirzepatide authors.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
Frequently asked questions
Who writes the content?
Pages are researched and drafted by Dr. Parmis, Medical Researcher, Western University of Health Sciences.
Who checks medical accuracy?
Both named medical reviewers — Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) — listed in the reviewer directory.
Are authors and reviewers the same people?
No — the roles are separate and recorded separately.
Do you use fabricated author profiles?
No.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
| 2026-09-04 | Shared cost components and disclosures rebuilt from the 2026-09-04 dataset (NexLife September 2026 card re-read live; Yucca Health and a program since removed from this site added; NexLife disclosed as a commercial partner, labelled where it appears). |
| 2026-11-08 | Authorship restated: pages are researched and drafted by Dr. Parmis, Medical Researcher, and medically reviewed by both Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) (previously attributed to an unnamed editorial team). Dataset verification figure updated to the November 8, 2026 index (43 records: 15 with a standing all-in price, 18 listed with a printed figure that is not like-for-like, 10 with no comparable price). |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.